| Enfermedad cardiovascular NCT05284747 | Fase 4 | En marcha, sin reclutar |
| Enfermedad coronaria, Hipercolesterolemia NCT07803679 | Fase 4 | Aún sin reclutar |
| VESALIUS-CV NCT03872401 | Fase 3 | Completado |
| FOURIER OLE NCT02867813 | Fase 3 | Completado |
| Fourier Open-label Extension Study in Subjects With Clinically Evident Cardiovascular Disease in Selected European Countries NCT03080935 | Fase 3 | Interrumpido |
| HAUSER-OLE NCT02624869 | Fase 3 | Completado |
| Imaging of Coronary Plaques in Participants Treated With Evolocumab NCT03570697 | Fase 3 | Completado |
| Evolocumab Pregnancy Exposure Registry NCT02957604 | no aplica | Interrumpido |
| Safety and Efficacy of Evolocumab in Addition to Optimal Stable Background Statin Therapy in Chinese Participants With Primary Hypercholesterolemia and Mixed Dyslipidemia NCT03433755 | Fase 3 | Interrumpido |
| RAMAN NCT03403374 | Fase 4 | Completado |
| HAUSER-RCT NCT02392559 | Fase 3 | Completado |
| Safety, Tolerability and Efficacy on Low Density Lipoprotein Cholesterol (LDL-C) of Evolocumab in Participants With Human Immunodeficiency Virus (HIV) and Hyperlipidemia/Mixed Dyslipidemia NCT02833844 | Fase 3 | Completado |
| Hipercolesterolemia NCT01439880 | Fase 2 | Completado |
| OSLER-2 NCT01854918 | Fase 3 | Completado |
| TAUSSIG NCT01624142 | Fase 2/3 | Completado |
| ANITSCHKOW NCT02729025 | Fase 3 | Completado |
| Hipercolesterolemia NCT02304484 | Fase 3 | Completado |
| BERSON NCT02662569 | Fase 3 | Completado |
| Hipercolesterolemia NCT02634580 | Fase 3 | Completado |
| Hipercolesterolemia, Diabetes tipo 2 NCT02739984 | Fase 3 | Completado |
| FOURIER NCT01764633 | Fase 3 | Completado |
| EBBINGHAUS NCT02207634 | Fase 3 | Completado |
| Hipercolesterolemia NCT02585895 | Fase 3 | Completado |
| Hipercolesterolemia NCT01813422 | Fase 3 | Completado |
| FLOREY NCT02189837 | Fase 3 | Completado |
| Estimation Study to Assess the Effect of Severe Renal Impairment and End-stage Renal Disease Hemodialysis on the Pharmacokinetics of Evolocumab NCT02275156 | Fase 1 | Completado |
| TESLA NCT01588496 | Fase 2/3 | Completado |
| RUTHERFORD-2 NCT01763918 | Fase 3 | Completado |
| GAUSS-2 NCT01763905 | Fase 3 | Completado |
| LAPLACE-2 NCT01763866 | Fase 3 | Completado |
| Hipercolesterolemia NCT01516879 | Fase 3 | Completado |
| MENDEL-2 NCT01763827 | Fase 3 | Completado |
| AMG145 NCT01652703 | Fase 2 | Completado |
| RUTHERFORD NCT01375751 | Fase 2 | Completado |
| GAUSS NCT01375764 | Fase 2 | Completado |
| LAPLACE NCT01380730 | Fase 2 | Completado |
| MENDEL NCT01375777 | Fase 2 | Completado |
| Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Evolocumab (AMG 145) in Adults With Hyperlipidemia on Stable Doses of a Statin NCT01133522 | Fase 1 | Completado |